Invectys élu « meilleur projet – jeune entreprise » 2019 par le Board international de MATWIN Invectys, société biopharmaceutique développant des thérapies…
Bio International Convention 2019 June 3 – 6th 2019 Pennsylvania Convention Center, Philadelphia, Pennsylvania, USA Invectys will be attending the BIO International…
ASCO Annual meeting 2019 May 31st – June 4th 2019 McCormick Place, Chicago, Illinois, USA Invectys will be attending the 2019 ASCO Annual Meeting,…
The main product of Invectys is a DNA vaccine targeting Telomerase…
The telomerase enzyme functions as part of a large ensemble of proteins and RNA called the telomerase ribonucleoprotein complex.…
Monoclonal antibodies targeting checkpoint inhibitors are hugely important immunotherapy molecules for the treatment cancers…
